Black Rock Inc. Cytokinetics Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Black Rock Inc. holds 14,672,779 shares of CYTK stock, worth $772 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,672,779
Previous 12,414,773
18.19%
Holding current value
$772 Million
Previous $870 Million
8.67%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Vanguard Group Inc Valley Forge, PA11.4MShares$602 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$428 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$395 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$345 Million0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.58MShares$241 Million29.98% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.96B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...